Titus MFM Plattel, MSc, MBA
Senior Vice President & Chief Operating Officer


Titus Plattel is the Chief Operating Officer for BERG.  His experience spans over 25 years in global biotech companies which gave Titus a broad experience in all facets of product development and commercialization of innovative therapies across different therapeutic areas. His professional experience spans key functions of product development including program management, portfolio analyses, product marketing and market analysis, pre-launch prep and final product launch by all sales and marketing functions involved.

Prior to joining Berg, he worked with emerging biotech ventures where he held executive and management roles at Therion Biologics, Tolerx and Bavarian Nordic, combining product development roles and commercialization responsibilities. Previously he has worked as part of the global launch of Amevive for Biogen, where he also worked on the in-licensing of tecfidera.  Titus received his MBA from Pepperdine University and his MSc from the University of Nijmegen, The Netherlands.